To assess whether the presence of Barrett's esophagus (BE) modifies the results of Nissen fundoplication. Between 1982 and 2000, 270 patients with GERD underwent NF in the University Hospital V Arrixaca in Murcia.
Summary Background Data
Some authors consider that BE, whether or not there is associated stricture, significantly increases the failure rate of standard antireflux surgery; they recommend using different and more aggressive surgical procedures in all patients with BE.
Methods
One hundred seventy-seven patients with gastroesophageal reflux disease, without esophageal stricture, were included in a retrospective study. Patients were divided into two groups: those with BE (n ϭ 57) and those without BE (n ϭ 120). Nis-sen fundoplication was performed in all patients by the same surgical team. Clinical, endoscopic, and functional (manometry and 24-hour pH monitoring) results in the two study groups were compared.
Results
After a median follow-up of 5 years (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] in the BE group and 6 years (range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] in the non-BE group, the rate of clinical recurrence was 8% in the BE group and 10% in the non-BE group, with no statistically significant difference. The rate of pH-metric recurrence was the same in both groups (15%).
Conclusions
The presence of BE without esophageal stricture does not increase the rate of failure of Nissen fundoplication.
Treatment of Barrett's esophagus (BE) is controversial and aims not only to control symptoms but also to prevent the BE from progressing to dysplasia and adenocarcinoma. The options are lifelong conservative treatment and antireflux surgery. As both are equally efficient in controlling symptoms and neither can cause the metaplastic segment to disappear, 1-4 some authors recommend conservative treatment because it is less aggressive, [5] [6] [7] [8] whereas others consider surgery as the treatment of choice.
When considering what type of antireflux surgery should be performed in patients with BE, some authors 2,9 -12 advocate that the presence of BE does not imply the use of any surgical procedures different from the standard antireflux operations, since, when there is no associated esophageal stricture, they obtain similar results to those obtained in patients without BE. In contrast, others [13] [14] [15] consider that the presence of BE, whether or not there is associated stricture, significantly increases the failure rate of standard antireflux surgery, and they suggest using different surgical procedures from the standard antireflux repairs in all patients with BE. Since these procedures are more difficult to perform than the standard technique, it is important to determine if the presence of BE (without esophageal stricture) increases the rate of failure of Nissen fundoplication (NF).
The aim of this retrospective study was to assess the results of NF in patients with BE and compare them to those of patients with gastroesophageal reflux disease (GERD) without BE.
Excluded from the study were patients with esophageal stricture (n ϭ 58), as it can produce an esophageal shortening that may worsen the results of surgery, and patients undergoing surgery via the laparoscopic approach (n ϭ 35), to eliminate the influence of the learning curve, because they were the first patients in whom this approach was used. The study population consisted of 177 patients divided into two groups: patients with BE (n ϭ 57) and patients without BE (n ϭ 120). BE was considered, until 1997, to be the presence of columnar epithelium over 3 cm in length continuing into the cardia and confirmed histologically; from 1997 onwards, patients with short Barrett's segment with intestinal metaplasia were also included.
The two study groups were homogeneous with respect to age, sex, and clinical data ( Table 1) . With respect to the endoscopic and histologic data, in the BE group 38 of 57 patients (67%) had added inflammatory lesions, and lowgrade dysplasia was present in 5 patients (9%). In the patients without BE, according to the Savary-Miller classification, 16 11 (9%) had no esophagitis, 40 (33%) had esophagitis grade 1, 26 (22%) had esophagitis grade 2, 29 (24%) had esophagitis grade 3, and the remaining 14 (12%) had esophagitis grade IV (ulcers).
Preoperative manometric and pH-metric data are shown in Table 2 .
In the BE group, surgery was indicated by the presence of BE, in the context of a randomized prospective study comparing medical to surgical treatment. 2 In the patients without BE, surgery was indicated by early recurrence of reflux symptoms after stopping medical treatment (n ϭ 90), by persistent regurgitation despite medical treatment (n ϭ 18), and by chronic anemia syndrome with digestive bleeding (n ϭ 12).
Surgical treatment, always performed by the same surgical team, consisted in all cases of a short NF (1.5-3 cm) over a 48 to 50 French bougie through a laparotomy. Short gastric vessels were divided if there was difficulty in mobilizing the gastric fundus, which occurred in 66 cases (37%). To prevent the fundoplication from sliding towards the thorax, the wrap was sutured to the diaphragm, and in all cases we reduced the size of the hiatus by joining the right and left limbs of the crura posterior to the esophagus with one to three sutures of nonabsorbable material.
Median follow-up in the BE group was 5 years (range 1-18) and in the group with GERD without BE mean follow-up was 6 years (range 1-18). In the BE group (n ϭ 57), 53 patients underwent annual clinical, endoscopic, and histologic assessment. In the group with GERD without BE (n ϭ 120), 108 patients underwent clinical assessment annually, whereas endoscopic study was performed in 99 patients 1 year and every 5 years postoperatively or when symptoms of recurrence appeared. Functional studies (esophageal manometry and 24-hour pH monitoring) were performed in 41 patients from the BE group and in 52 patients from the non-BE group. These studies were carried out 1 year and every 5 years postoperatively or when symptoms of recurrence appeared.
Clinical assessment was done annually by direct interview, following a questionnaire directed towards discovering the presence of reflux symptoms and undesirable side effects of NF (e.g., dysphagia, postprandial fullness, inability to belch or vomit). The survey in all cases was carried out separately by the same two surgeons, who later compared results. The results were classified as follows: excellent (asymptomatic), good (minimal symptoms requiring no therapy), fair (improved but with heartburn requiring intermittent therapy), and poor (unimproved or worse).
The endoscopic study was performed in all patients by the same endoscopist. In patients with BE, the length of the metaplastic segment was measured by taking the incisors, squamocolumnar junction, and cardia as reference points. Progression or regression of BE was considered when the length of the metaplastic segment increased or decreased at least 1 cm compared to the length before therapy. Multiple biopsies were taken systematically during endoscopy as described previously. 2 Dysplasia was graded according to Rydell et al. 17 Functional studies were carried out according to the methodology previously described. 2 The mean, standard deviation, medians, and range were calculated for all data. The comparisons between the two groups were performed with the Student t test for quantitative variables and with the chi-square Pearson test for qualitative variables. The comparisons between data before and after each type of treatment were performed with the Student t test for quantitative variables and with the McNemar test for qualitative variables.
RESULTS
There were no postoperative mortalities. With respect to morbidity and hospital stay, there were no statistically significant differences between the two groups ( Table 3) .
From the clinical point of view, with regard to the efficiency of NF in controlling gastroesophageal reflux, the percentage of unsatisfactory results (fair to poor) was 8% in the BE group and 10% in the non-BE group, with no statistically significant differences (Table 4 ). Side effects of surgery, mild and transitory in all cases, are shown in Table   4 ; there were no statistically significant differences between the two groups.
With respect to the endoscopic results, in the patients with BE, NF caused added inflammatory lesions to disappear in 35 of the 36 who presented with it (97%). However, the metaplastic segment persisted in all cases. Low-grade dysplasia disappeared in all patients in whom it was present preoperatively (n ϭ 5), all of them with successful antireflux procedure, but dysplasia de novo appeared after surgery in three cases, evolving to high-grade dysplasia in two of them 4 and 6 years postoperatively. These two patients showed clinical and pH-metric recurrence of gastroesophageal reflux 1 year postoperatively (percentage of total time with pH Ͻ 4 was 12% and 37%, respectively). These two patients underwent an esophageal resection, and an adenocarcinoma was found in both cases. In the patients without BE, NF induced healing of the esophagitis in 87 of 99 patients (88%). Of the remaining 12 cases, esophagitis improved in 6 (from grade 2 to grade 1), remained unchanged in 3, and worsened (developed a mild stricture) in the other 3. Table 5 shows the results of the postoperative functional studies. NF improved the mechanical condition of the lower esophageal sphincter and the quality of esophageal peristalsis in both groups. Although there was a significant decrease in the mean percentage of total time with pH less than 4 in both groups, 6 of the 41 patients (15%) in the BE group and 8 of the 52 patients (15%) in the group without BE showed pathologic rates of acid reflux. Table 6 shows the correlation between clinical, endoscopic, and pH-metric data in all patients with pH-metric recurrence of gastroesophageal reflux.
DISCUSSION
The gold standard for antireflux surgery is currently considered to be 360°NF: it has proved more efficient than any other technique for controlling medium-and long-term reflux. 9,18 -20 The presence of esophageal stenosis with or without BE is associated with worse results for standard antireflux surgery, as it increases the rate of reflux recurrence, which accounts for some 20% to 40% of cases. [21] [22] [23] This has been related to the esophageal shortening that accompanies stenosis and that, in some cases, prevents the surgeon from obtaining a sufficient length of abdominal esophagus to perform a tension-free fundoplication. Performing a Collis gastroplasty associated with a total (Nissen) fundoplication 24 or a partial (Belsey) fundoplication 25 in these patients reduces the rate of recurrence compared to standard antireflux surgery, although it is technically more difficult and involves higher morbidity and mortality.
When considering what type of antireflux surgery should be performed in patients with BE, some authors 2,9 -12 consider that the presence of BE does not imply the use of any surgical procedures different from the standard antireflux operations, since when there is no associated esophageal stenosis they obtain similar results to those obtained in patients without BE. Our results show that the long-term efficiency of NF is similar in both groups of patients not only from the subjective point of view but also from the more objective point of view (24-hour pH monitoring). Similar results have been reported by other authors with the laparoscopic approach 11, 12 in larger series of patients. However, these studies have a shorter follow-up and lack postoperative objective evaluations with functional studies in most cases. In contrast, others [13] [14] [15] consider that the mere presence of BE, whether or not there is associated stenosis, significantly increases the failure rate of standard antireflux surgery, and they suggest using different surgical procedures from the standard antireflux repairs in all patients with BE. Csendes et al., 26 in 164 patients with BE treated with NF or posterior gastropexy, reported a 23% failure rate for patients without BE and 83% for those with BE after 10 years. To avoid these disappointing results, they had suggested previously 14 associating standard antireflux surgery with the duodenal switch procedure described by De Meester et al. in 1987 27 to control pathologic duodenogastric reflux. They added a highly selected vagotomy to prevent anastomotic ulcer. 14 This new approach was supported by the results obtained in 65 patients operated on between 1992 and 1996. Although the mean follow-up was short, they concluded that the operation can be done safely, improves the clinical situation of the patient in 90% of cases. and controls both acid and biliopancreatic reflux to the esophagus, with the dysplasia disappearing in 3 of 12 patients. However, 3 years later these same authors 28 reported the results of this procedure in 66 patients divided into two groups-uncomplicated (n ϭ 45) and complicated (with ulcers or stenosis; n ϭ 21) BE-and concluded that the technique offers excellent results only in patients with uncomplicated BE, whereas in patients with complicated BE the recurrence rate was higher (8/18 ulcers and 2/3 stenosis). The authors attributed this to the persistence of acid reflux into the esophagus and suggested a more aggressive procedure for these patients (antireflux surgery with vagotomy, gastrectomy, and Rouxen-Y gastrojejunostomy).
Chen et al. 13 argued that in BE the esophagus is always shortened, even if there is no stenosis, exposing the patient Surgical Treatment of Barrett's Esophagus to the failure rate reported when stenosis does exist. They proposed performing a Collis-Nissen procedure through a left thoracotomy in all patients with BE. They based their proposal on the results obtained in 45 patients with a mean follow-up of 35.9 months. Collis-Nissen gastroplasty controls the symptoms and the mucosal damage, without regression of the metaplastic segment, and restores the lower esophageal sphincter gradient, although it increases the resistance to bolus transit. Furthermore, 22% of the patients showed a pathologic rate of acid reflux (median percentage of total time with pH Ͻ 4 of 13.5%), perhaps related, in the authors' opinion, to the continuous secretion of acid by the epithelium of the neoesophagus. Although our opinion does not detract from the excellent results reported by these authors, we disagree with performing these operations in all patients with BE. First, these procedures are more difficult to perform than the standard technique (they involve a longer operating time and higher morbidity and mortality) and cannot easily be performed by most surgeons through a laparoscopic approach (an important issue in a highly prevalent clinical situation). Second, in our experience and in that of others, 2,4,10 -12,15,29 -35 standard antireflux surgery achieves excellent results in most cases. On the other hand, several functional studies have shown that standard antireflux surgery efficiently controls both acid 2, 9, 11 and biliopancreatic 36 reflux into the esophagus.
However, these procedures can be indicated in some cases. Collis-Nissen gastroplasty, as already mentioned, might be indicated when esophageal shortening prevents a tension-free NF from being performed. Duodenal switch could be indicated in truly exceptional cases in which, after multiple failures with standard antireflux surgery, approaching the esophagogastric junction to redo the NF is extremely difficult.
Gastal et al. 37 preoperatively suspect an esophageal shortening in patients with a hiatal hernia of 5 cm or larger, a nonreducible hernia, or an esophageal stricture. In such cases they propose a transthoracic approach to assess esophageal length intraoperatively. If the length of the esophagus after mobilizing it from the diaphragmatic hiatus up to the aortic arch does not allow the esophagogastric junction to be placed without tension in the abdomen, they perform a Collis gastroplasty and Belsey partial fundoplication. Following these criteria on a total of 236 patients with symptomatic GERD and effective esophageal body motility, they performed a laparoscopic Nissen procedure in 171 patients and a transthoracic approach in the remaining 65. Twentyeight of these 65 were judged intraoperatively to have sufficient esophageal length, whereas 37 required an additional lengthening procedure (Collis gastroplasty). In our experience and in that of others, 38 the degree of esophageal shortening can only be assessed during the operation; this is why we do not share the criteria of these authors for precluding standard antireflux surgery. Although in cases of BE with stenosis the rate of recurrences with standard antireflux surgery suggests a certain optimism on the part of the surgeon regarding the length of abdominal esophagus obtained, and esophageal lengthening should probably be done in a greater number of cases, we must not go to the other extreme and perform more aggressive surgery in patients who might benefit from standard antireflux surgery by the laparoscopic approach, 11, 12 as occurred in 12% of Gastal et al.'s patients, 37 since the esophagus mobilization can be done through the abdominal approach.
In summary, our results show that the mere presence of BE does not increase the rate of clinical or pH-metric recurrence of reflux after NF. Therefore, we find no justification for depriving patients with BE and without esophageal stricture of the standard antireflux procedures.
